NeoGenomics
143 hedge funds and large institutions have $481M invested in NeoGenomics in 2017 Q1 according to their latest regulatory filings, with 20 funds opening new positions, 40 increasing their positions, 49 reducing their positions, and 14 closing their positions.
49,250% more call options, than puts
Call options by funds: $987K | Put options by funds: $2K
43% more first-time investments, than exits
New positions opened: 20 | Existing positions closed: 14
0% more funds holding
Funds holding: 143 → 143 (0)
0% more funds holding in top 10
Funds holding in top 10: 6 → 6 (0)
0.96% less ownership
Funds ownership: 78.34% → 77.38% (-0.96%)
9% less capital invested
Capital invested by funds: $527M → $481M (-$46M)
18% less repeat investments, than reductions
Existing positions increased: 40 | Existing positions reduced: 49
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$27.1M |
| 2 |
JHIU
Janus Henderson Investors US
Denver,
Colorado
|
+$13.7M |
| 3 |
GF
Gabelli Funds
Rye,
New York
|
+$2.88M |
| 4 |
ICM
IronBridge Capital Management
Oakbrook Terrace,
Illinois
|
+$2.56M |
| 5 |
Renaissance Technologies
New York
|
+$2.51M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
-$8.46M |
| 2 |
CM
Castleark Management
Chicago,
Illinois
|
-$8.32M |
| 3 |
NCGI
Next Century Growth Investors
Plymouth,
Minnesota
|
-$3.99M |
| 4 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$2.96M |
| 5 |
Russell Investments Group
London,
United Kingdom
|
-$2.62M |
NEO Hedge Fund Activity: Q1 2017 in Review
143 of the 4,034 institutional investors tracked by Wall St. Rank reported a position in NeoGenomics (NEO) for Q1 2017, worth a combined $481M — down 8.7% from $527M a quarter earlier.
Buyers outnumbered sellers: 20 funds opened new NEO positions and 14 closed out — a net gain of 6 holders — while 40 added to existing stakes and 49 trimmed.
The largest buyer was BlackRock, adding an estimated $27.1M. The largest seller was Granahan Investment Management, cutting an estimated $8.46M.
- 143 institutional investors held NeoGenomics (NEO) as of Q1 2017, unchanged from Q4 2016.
- Funds reported $481M of NeoGenomics stock for Q1 2017, down 8.7% quarter-over-quarter.
- 20 funds opened new NeoGenomics positions in Q1 2017 and 14 closed out, a net change of +6 holders.
- The largest NeoGenomics buyer in Q1 2017 was BlackRock, an estimated $27.1M added.
- The largest NeoGenomics seller in Q1 2017 was Granahan Investment Management, an estimated $8.46M sold.
Based on aggregated 13F filings for Q1 2017.